(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -0.84%36.82B | 3.30%18.53B | 8.42%79.98B | 9.59%55.84B | 12.02%37.13B | 16.90%17.94B | 6.10%73.77B | 9.08%50.96B | 5.00%33.15B | 5.12%15.35B |
Operating income | -0.84%36.82B | 3.30%18.53B | 8.42%79.98B | 9.59%55.84B | 12.02%37.13B | 16.90%17.94B | 6.10%73.77B | 9.08%50.96B | 5.00%33.15B | 5.12%15.35B |
Cost of sales | 1.43%-33.72B | ---- | -9.30%-74.53B | ---- | -12.19%-34.21B | ---- | -5.23%-68.19B | ---- | -4.16%-30.49B | ---- |
Operating expenses | 1.43%-33.72B | -2.45%-17.07B | -9.30%-74.53B | -9.59%-51.92B | -12.19%-34.21B | -17.33%-16.66B | -5.23%-68.19B | -7.87%-47.37B | -4.16%-30.49B | -2.94%-14.2B |
Gross profit | 6.10%3.1B | 14.32%1.47B | -2.43%5.45B | 9.57%3.93B | 10.03%2.92B | 11.61%1.28B | 17.98%5.59B | 28.03%3.58B | 15.79%2.65B | 42.36%1.15B |
Selling expenses | 8.21%-28.84M | -0.28%-12.73M | -10.19%-82.69M | -12.67%-46.96M | -17.93%-31.42M | -3.76%-12.69M | 6.73%-75.04M | 21.54%-41.68M | 21.72%-26.64M | 20.17%-12.23M |
Administrative expenses | 7.50%-960.3M | 3.53%-465.43M | -3.96%-2.39B | 4.66%-1.48B | 4.93%-1.04B | 2.25%-482.48M | -5.43%-2.3B | -17.41%-1.56B | -22.90%-1.09B | -28.93%-493.6M |
Research and development expenses | -36.91%-1.12B | -142.72%-511.54M | -13.31%-2.08B | -4.15%-1.12B | -22.22%-815.11M | 32.11%-210.76M | -10.14%-1.84B | -86.07%-1.08B | -91.08%-666.92M | -261.72%-310.44M |
Profit from asset sales | ---- | 168.80%4.27M | ---- | -42.28%16.62M | ---- | -280.66%-6.2M | ---- | -56.34%28.8M | ---- | 54.02%3.43M |
Impairment and provision | 72.57%264.85M | 113,526.85%122.72M | 1,755.83%403.24M | 400.94%150.25M | 121.34%153.47M | -97.46%108K | -23.83%-24.35M | -18.02%29.99M | 70.61%69.34M | -76.85%4.25M |
-Other impairment is provision | 72.57%264.85M | 113,526.85%122.72M | 1,755.83%403.24M | 400.94%150.25M | 121.34%153.47M | -97.46%108K | -23.83%-24.35M | -18.02%29.99M | 70.61%69.34M | -76.85%4.25M |
Operating interest expense | ---- | ---- | -42.46%-894.07M | ---- | ---- | ---- | 27.37%-627.6M | ---- | 30.94%-281.89M | ---- |
Special items of operating profit | 266.68%167.8M | -2.22%20.42M | 175.39%22.04M | -48.22%35.6M | --45.76M | -18.02%20.88M | -9.63%8M | -66.17%68.74M | ---- | -57.60%25.47M |
Operating profit | 15.48%1.43B | 2.74%541.17M | -41.95%420.66M | 53.38%1.3B | 88.23%1.24B | 66.17%526.72M | 1,065.12%724.67M | -15.71%849.58M | 0.47%656.14M | -10.47%316.98M |
Financing cost | 7.42%-346.09M | 24.71%-189.31M | ---- | -55.09%-628.52M | ---373.82M | -34.59%-251.43M | ---- | 33.34%-405.27M | ---- | -6.65%-186.82M |
Share of profits of associates | 25.11%4.07M | ---- | ---- | ---- | 22.24%3.25M | ---- | ---- | ---- | -19.09%2.66M | ---- |
Share of profit from joint venture company | -706.11%-1.59M | ---- | ---- | ---- | 172.92%262K | ---- | ---- | ---- | 104.26%96K | ---- |
Special items of earning before tax | ---- | 42.12%-19.29M | 339.62%494.54M | -9.00%35.59M | ---- | -1,196.42%-33.32M | -78.62%112.49M | -23.28%39.11M | -38.34%73.85M | -122.92%-2.57M |
Earning before tax | 25.20%1.08B | 37.44%332.57M | 9.32%915.21M | 46.89%710.13M | 18.02%864.79M | 89.64%241.97M | 85.55%837.16M | 7.21%483.43M | -5.60%732.75M | -32.88%127.6M |
Tax | -52.90%-329.76M | -60.14%-155.11M | -33.80%-339.12M | -34.61%-266.52M | -26.07%-215.67M | -81.33%-96.86M | 18.43%-253.46M | -51.65%-197.99M | -108.73%-171.07M | -118.51%-53.42M |
After-tax profit from continuing operations | 16.00%752.95M | 22.29%177.47M | -1.30%576.08M | 55.41%443.61M | 15.57%649.12M | 95.63%145.11M | 315.59%583.7M | -10.90%285.44M | -19.09%561.68M | -55.22%74.18M |
Earning after tax | 16.00%752.95M | 22.29%177.47M | -1.30%576.08M | 55.41%443.61M | 15.57%649.12M | 95.63%145.11M | 315.59%583.7M | -10.90%285.44M | -19.09%561.68M | -55.22%74.18M |
Profit attributable to shareholders | 16.00%752.95M | 22.29%177.47M | -1.30%576.08M | 55.41%443.61M | 15.57%649.12M | 95.63%145.11M | 315.59%583.7M | -10.90%285.44M | -19.09%561.68M | -55.22%74.18M |
Basic earnings per share | 17.65%0.04 | 12.50%0.009 | -3.23%0.03 | 53.33%0.023 | 13.33%0.034 | 100.00%0.008 | 342.86%0.031 | -11.76%0.015 | -18.92%0.03 | -60.00%0.004 |
Diluted earnings per share | 17.65%0.04 | 12.50%0.009 | -3.23%0.03 | 53.33%0.023 | 13.33%0.034 | 100.00%0.008 | 342.86%0.031 | -11.76%0.015 | -18.92%0.03 | -60.00%0.004 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership), Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data